Zelboraf – New Skin Cancer Drug


'Zelboraf was approved in 2011 for use in late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer. Melanoma is the leading cause of death from skin disease. The National Cancer Institute estimated that 68,130 new cases of melanoma were diagnosed in the United States during 2010; about 8,700 people died from the disease.

Zelboraf, the new expensive drug to treat advanced skin cancer, or metastatic melanoma, allows people to die more slowly, twice as slowly in fact. Instead of dying in about nine months, now those with this deadly cancer can stretch out their suffering for a full six months longer and pay a fortune for the privilege of having their death extended in such a torturous fashion.'


No comments: